A similar logic applies in the funds universe. Behemoths such as Fundsmith Equity (GB00B4Q5X527) draw plenty of attention, but smaller portfolios can show plenty of promise. On top of this, a manager ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...

Axial Spondyloarthritis (axSpA) is a form of arthritis that mainly causes discomfort and inflammation in the spine and ...

The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) ...

A recent UPC ruling involving Novartis has major implications for determining jurisdiction, claim interpretation and imminent ...

Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The global pharmaceutical drug delivery market is set to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029 ...